Are We Making Progress in Lung Cancer Using Progression-Free Survival as a Surrogate End Point?

被引：3
|
作者：
Shyr, Yu [1 ]
Horn, Leora [2 ]
Berry, Lynne [1 ]
机构：
[1] Vanderbilt Univ, Ctr Quantitat Sci, 2220 Pierce Ave,571 PRB, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Med, Div Hematol & Oncol, Nashville, TN USA
来源：
JAMA ONCOLOGY | 2015年 / 1卷 / 02期
关键词：
CHEMOTHERAPY; CRIZOTINIB;
D O I：
10.1001/jamaoncol.2015.0407
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：202 / 203
页数：3
相关论文
共 50 条
  • [1] Progression-free survival end points in prostate cancer: are we truly making progress
    Madan, Ravi A.
    Posadas, Edwin M.
    Lee, Richard J.
    NATURE REVIEWS UROLOGY, 2024, : 646 - 648
  • [2] SIRFLOX: Progression-Free Survival in the Liver As a Surrogate End Point for Survival?
    Ayoola, Adeola O.
    Ibraheem, Abiola F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (34) : 4193 - +
  • [3] The validity of progression-free survival 2 as a surrogate trial end point for overall survival
    Woodford, Rachel G.
    Zhou, Deborah D. X.
    Kok, Peey-Sei
    Lord, Sally J.
    Friedlander, Michael
    Marschner, Ian C.
    Simes, R. John
    Lee, Chee Khoon
    CANCER, 2022, 128 (07) : 1449 - 1457
  • [4] Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literature
    Saad, E. D.
    Katz, A.
    Hoff, P. M.
    Buyse, M.
    ANNALS OF ONCOLOGY, 2010, 21 (01) : 7 - 12
  • [5] Progression-free Survival as a Surrogate End-point in Advanced Colorectal Cancer Treated with Antiangiogenic Therapies
    Montagnani, Francesco
    Di Leonardo, Greta
    Pino, Maria Simona
    Martella, Francesca
    Perboni, Simona
    Ribecco, Angela
    Fioretto, Luisa
    ANTICANCER RESEARCH, 2016, 36 (08) : 4259 - 4265
  • [6] A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL
    Dimier, Natalie
    Delmar, Paul
    Ward, Carol
    Morariu-Zamfir, Rodica
    Fingerle-Rowson, Guenter
    Bahlo, Jasmin
    Fischer, Kirsten
    Eichhorst, Barbara
    Goede, Valentin
    van Dongen, Jacques J. M.
    Ritgen, Matthias
    Boettcher, Sebastian
    Langerak, Anton W.
    Kneba, Michael
    Hallek, Michael
    BLOOD, 2018, 131 (09) : 955 - 962
  • [7] Before We Throw out Progression-Free Survival As a Valid End Point ...
    Stewart, David J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27) : 3426 - 3427
  • [8] Progression-free survival is a surrogate for survival in advanced colorectal cancer
    Buyse, Marc
    Burzykowski, Tomasz
    Carroll, Kevin
    Michiels, Stefan
    Sargent, Daniel J.
    Miller, Langdon L.
    Elfring, Gary L.
    Pignon, Jean-Pierre
    Piedbois, Pascal
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) : 5218 - 5224
  • [9] Validity and Efficiency of Progression-Free Survival-2 as a Surrogate End Point for Overall Survival in Advanced Cancer Randomized Trials
    Woodford, Rachel
    Zhou, Deborah
    Kok, Peey-Sei
    Lord, Sally J.
    Friedlander, Michael
    Marschner, Ian
    Simes, R. John
    Lee, Chee Khoon
    JCO PRECISION ONCOLOGY, 2024, 8
  • [10] Is It Premature to Accept Radiographic Progression-Free Survival as a Surrogate End Point in Metastatic Hormone-Sensitive Prostate Cancer?
    Garcia, Jorge A.
    Spratt, Daniel E.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (24)
12345